In consideration that MEIS1 can also induce FLT3 gene expression, combined treatment of NPM1mut/FLT3-ITDhigh AML patients with menin inhibitors and FLT3 inhibitors might represent a promising approach [127,133,134]. This evidence concerns the gene MEN1 and acute myeloid leukemia.